Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
In this webinar, IsoPlexis product manager Victor Tek discusses how researchers used IsoPlexis’ low volume highly multiplexed bulk proteomics (CodePlex) to investigate the role of airway and plasma immune cells in the pathogenesis of severe COVID-19. Learn more about how IsoPlexis technology can accelerate your current or future research projects.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.